Intersect ENT Other Current Liabilities

Intersect ENT (XENT) currently reports a other current liabilities of $37M as of March 2022. That compares with $37M in the prior-year period — up 1.7% year over year. Use the charts on this page to explore Intersect ENT's other current liabilities history and peer comparisons.

Intersect ENT's other current liabilities increased from $37M to $37M — a 1.7% year-over-year increase (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Intersect ENT reported $37M in other current liabilities as of March 2022. That compares with $37M in the prior-year period — up 1.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $37M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Intersect ENT, and consider following XENT for alerts when major investors trade the stock.

Intersect ENT is classified in the Healthcare sector. On other current liabilities, it currently shows $37M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing XENT with unrelated industries.